Vapotherm
Develops and manufactures innovative, comfortable, noninvasive technologies for respiratory support of patients with chronic or acute breathing disorders. Learn more
Launch date
Employees
Market cap
CAD18.4m
Enterprise valuation
CAD182m (Public information from Sep 2024)
Share price
$2.17 VAPO
Exeter United States (HQ)
Authorizing premium user...